Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Murray Korc

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Phenomena

Northern Blotting

Anatomy

Procedures

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
97
Friess, Helmut
78
Büchler, Markus
49
Kleeff, Jörg
28
Zimmermann, Arthur
21
Kornmann, Marko
20
Beger, Hans
17
Ishiwata, Toshiyuki
15
Graber, Hans
12
Lopez, Martha
7
Berberat, Pascal
6
Giese, Thomas
6
Gold, LI
6
Itakura, Jun
5
Chandrasekar, Bysani
5
di Mola, Fabio

Sign-in to see all Coauthors

Publications

TOP 3
Korc Murray
Smad4: gatekeeper gene in head and neck squamous cell carcinoma.
Trask Heidi W; Cowper-Sal-lari Richard; Sartor Maureen A; Gui Jiang; Heath Catherine V; Renuka Janhavi; Higgins Azara-Jane; Andrews Peter; Korc Murray; Moore Jason H; Tomlinson Craig R
Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs.
Korc M; Friesel R E
The role of fibroblast growth factors in tumor growth.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Murray Korc (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Korc Murray
Smad4: gatekeeper gene in head and neck squamous cell carcinoma.
The Journal of clinical investigation 2009;119(11):3208-11.
2009: Trask Heidi W; Cowper-Sal-lari Richard; Sartor Maureen A; Gui Jiang; Heath Catherine V; Renuka Janhavi; Higgins Azara-Jane; Andrews Peter; Korc Murray; Moore Jason H; Tomlinson Craig R
Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs.
RNA (New York, N.Y.) 2009;15(10):1917-28.
2009: Korc M; Friesel R E
The role of fibroblast growth factors in tumor growth.
Current cancer drug targets 2009;9(5):639-51.
2009: Shin Sonyo; Asano Takayuki; Yao Yixin; Zhang Ronghua; Claret Francois-Xavier; Korc Murray; Sabapathy Kanaga; Menter David G; Abbruzzese James L; Reddy Shrikanth A G
Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.
Molecular cancer research : MCR 2009;7(5):745-54.
2009: Carrière Catherine; Young Alison L; Gunn Jason R; Longnecker Daniel S; Korc Murray
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras.
Biochemical and biophysical research communications 2009;382(3):561-5.
2009: Ketterer Knut; Kong Bo; Frank Dietwalt; Giese Nathalia A; Bauer Andrea; Hoheisel Jörg; Korc Murray; Kleeff Jörg; Michalski Christoph W; Friess Helmut
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway.
Cancer letters 2009;277(1):72-81.
2009: Liu Xi; Sempere Lorenzo F; Galimberti Fabrizio; Freemantle Sarah J; Black Candice; Dragnev Konstantin H; Ma Yan; Fiering Steven; Memoli Vincent; Li Hua; DiRenzo James; Korc Murray; Cole Charles N; Bak Mads; Kauppinen Sakari; Dmitrovsky Ethan
Uncovering growth-suppressive MicroRNAs in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1177-83.
2009: Kawamoto Masao; Ishiwata Toshiyuki; Cho Kazumitsu; Uchida Eiji; Korc Murray; Naito Zenya; Tajiri Takashi
Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer.
Human pathology 2009;40(2):189-98.
2009: Seeley E Scott; Carrière Catherine; Goetze Tobias; Longnecker Daniel S; Korc Murray
Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.
Cancer research 2009;69(2):422-30.
2009: Formentini Andrea; Prokopchuk Olga; Sträter Joern; Kleeff Joerg; Grochola Lukasz Filip; Leder Gerd; Henne-Bruns Doris; Korc Murray; Kornmann Marko
Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.
International journal of colorectal disease 2009;24(1):57-67.
2009: Bauer Andrea; Kleeff Jörg; Bier Melanie; Wirtz Martin; Kayed Hany; Esposito Irene; Korc Murray; Hafner Mathias; Hoheisel Jörg D; Friess Helmut
Identification of malignancy factors by analyzing cystic tumors of the pancreas.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2009;9(1-2):34-44.
2008: Neupane Divas; Korc Murray
14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7614-23.
2008: Whipple Chery; Korc Murray
Targeting angiogenesis in pancreatic cancer: rationale and pitfalls.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2008;393(6):901-10.
2008: Szafranska Anna E; Doleshal Martina; Edmunds Hayward S; Gordon Stuart; Luttges Jutta; Munding Johanna B; Barth Richard J; Gutmann Edward J; Suriawinata Arief A; Marc Pipas J; Tannapfel Andrea; Korc Murray; Hahn Stephan A; Labourier Emmanuel; Tsongalis Gregory J
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.
Clinical chemistry 2008;54(10):1716-24.
2008: Sempere Lorenzo F; Korc Murray
Shining the spotlight on shed KRAS in pancreatic cancer.
Cancer biology & therapy 2008;7(3):361-3.
2008: Aikawa Takuma; Whipple Chery A; Lopez Martha E; Gunn Jason; Young Alison; Lander Arthur D; Korc Murray
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.
The Journal of clinical investigation 2008;118(1):89-99.
2007: Matsushita Arikira; Götze Tobias; Korc Murray
Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Cancer research 2007;67(21):10309-16.
2007: Korc Murray
Pancreatic cancer-associated stroma production.
American journal of surgery 2007;194(4 Suppl):S84-6.
2007: Fukasawa Mitsuharu; Matsushita Akira; Korc Murray
Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion.
Cancer biology & therapy 2007;6(8):1173-80.
2007: Liu Zhanbing; Ishiwata Toshiyuki; Zhou Shaxia; Maier Susanne; Henne-Bruns Doris; Korc Murray; Bachem Max; Kornmann Marko
Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells.
Pancreas 2007;35(2):147-57.
2007: Cho Kazumitsu; Ishiwata Toshiyuki; Uchida Eiji; Nakazawa Nando; Korc Murray; Naito Zenya; Tajiri Takashi
Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer.
The American journal of pathology 2007;170(6):1964-74.
2007: Wildi Stefan; Kleeff Jörg; Mayerle Julia; Zimmermann Arthur; Böttinger Erwin P; Wakefield Lalage; Büchler Markus W; Friess Helmut; Korc Murray
Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations.
Gut 2007;56(5):685-92.
2007: Liu Zhanbing; Neiss Nicola; Zhou Shaoxia; Henne-Bruns Doris; Korc Murray; Bachem Max; Kornmann Marko
Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth.
Cancer research 2007;67(6):2712-9.
2007: Carrière Catherine; Seeley Elliott S; Goetze Tobias; Longnecker Daniel S; Korc Murray
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(11):4437-42.
2007: Kolb Armin; Kleeff Jörg; Arnold Nichole; Giese Nathalia A; Giese Thomas; Korc Murray; Friess Helmut
Expression and differential signaling of heregulins in pancreatic cancer cells.
International journal of cancer. Journal international du cancer 2007;120(3):514-23.
2007: Arnold Nichole Boyer; Arkus Nohea; Gunn Jason; Korc Murray
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):18-26.
2007: Chang Ken Chien-Neng; Komm Barry; Arnold Nichole Bayer; Korc Murray
The application of differential display as a gene profiling tool.
Methods in molecular biology (Clifton, N.J.) 2007;383():31-40.
2006: Kayed Hany; Kleeff Jörg; Keleg Shereen; Jiang Xiaohua; Penzel Roland; Giese Thomas; Zentgraf Hanswalter; Büchler Markus W; Korc Murray; Friess Helmut
Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
International journal of oncology 2006;29(5):1139-48.
2006: Tomlinson Craig R; Korc Murray
Squeezing data from pancreatic juice.
Cancer biology & therapy 2006;5(10):1390-1.
2006: Korc Murray
The joy of discovery.
Cancer biology & therapy 2006;5(7):884-8.
2006: Aikawa Takuma; Gunn Jason; Spong Suzanne M; Klaus Stephen J; Korc Murray
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.
Molecular cancer therapeutics 2006;5(5):1108-16.
2006: Ishiwata Toshiyuki; Kudo Mitsuhiro; Onda Munehiko; Fujii Takenori; Teduka Kiyoshi; Suzuki Taeko; Korc Murray; Naito Zenya
Defined localization of nestin-expressing cells in L-arginine-induced acute pancreatitis.
Pancreas 2006;32(4):360-8.
2006: Guo Junchao; Kleeff Jörg; Zhao Yupei; Li Junsheng; Giese Thomas; Esposito Irene; Büchler Markus W; Korc Murray; Friess Helmut
Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma.
International journal of molecular medicine 2006;17(5):761-7.
2006: Ebert Matthias P A; Korc Murray; Malfertheiner Peter; Röcken Christoph
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis.
Journal of proteome research 2006;5(1):19-25.
2006: Kayed Hany; Kleeff Jörg; Kolb Armin; Ketterer Knut; Keleg Shereen; Felix Klaus; Giese Thomas; Penzel Roland; Zentgraf Hanswalter; Büchler Markus W; Korc Murray; Friess Helmut
FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth.
International journal of cancer. Journal international du cancer 2006;118(1):43-54.
2005: Ding Kan; Lopez-Burks Martha; Sánchez-Duran José Antonio; Korc Murray; Lander Arthur D
Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
The Journal of cell biology 2005;171(4):729-38.
2005: Boyer Arnold Nichole; Korc Murray
Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
The Journal of biological chemistry 2005;280(23):21858-66.
2005: Chan John K; Pham Huyen; You Xue Juan; Cloven Noelle G; Burger Robert A; Rose G Scott; Van Nostrand Kristi; Korc Murray; Disaia Philip J; Fan Hung
Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.
Cancer research 2005;65(8):3243-8.
2005: Korc Murray
Targeted therapeutics in pancreatic cancer: a ray of hope.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):410-1.
2005: Yasutome Michiya; Gunn Jason; Korc Murray
Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Clinical & experimental metastasis 2005;22(6):461-73.
2004: Guweidhi Ahmed; Kleeff Jörg; Giese Nathalia; El Fitori Jamael; Ketterer Knut; Giese Thomas; Büchler Markus W; Korc Murray; Friess Helmut
Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
Carcinogenesis 2004;25(9):1575-85.
2004: Bloushtain Noga; Qimron Udi; Bar-Ilan Ahuva; Hershkovitz Oren; Gazit Roi; Fima Eyal; Korc Murray; Vlodavsky Israel; Bovin Nicolai V; Porgador Angel
Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2392-401.
2004: Li Junsheng; Kleeff Jörg; Kayed Hany; Felix Klaus; Penzel Roland; Büchler Markus W; Korc Murray; Friess Helmut
Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells.
Biochemical and biophysical research communications 2004;320(4):1148-55.
2004: Li Junsheng; Kleeff Jörg; Giese Nathalia; Büchler Markus W; Korc Murray; Friess Helmut
Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation.
International journal of oncology 2004;25(1):203-10.
2004: Fukasawa Mitsuharu; Korc Murray
Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3327-32.
2004: Arnold Nichole Boyer; Ketterer Knut; Kleeff Jörg; Friess Helmut; Büchler Markus W; Korc Murray
Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
Cancer research 2004;64(10):3599-606.
2004: Fukahi Kimi; Fukasawa Mitsuharu; Neufeld Gera; Itakura Jun; Korc Murray
Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):581-90.
2004: Guo Junchao; Kleeff Jörg; Li Junsheng; Ding Jiayi; Hammer Jürgen; Zhao Yupei; Giese Thomas; Korc Murray; Büchler Markus W; Friess Helmut
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma.
Oncogene 2004;23(1):71-81.
2004: Kleeff Jörg; Kothari Nayantara H; Friess Helmut; Fan Hung; Korc Murray
Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell lines.
Pancreas 2004;28(1):25-30.
2004: Korc Murray
Update on diabetes mellitus.
Disease markers 2004;20(3):161-5.
2003: Ketterer Knut; Rao Shyam; Friess Helmut; Weiss John; Büchler Markus W; Korc Murray
Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5127-36.
2003: Friess H; Ding J; Kleeff J; Fenkell L; Rosinski J A; Guweidhi A; Reidhaar-Olson J F; Korc M; Hammer J; Büchler M W
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer.
Cellular and molecular life sciences : CMLS 2003;60(6):1180-99.
2003: Korc Murray
Diabetes mellitus in the era of proteomics.
Molecular & cellular proteomics : MCP 2003;2(6):399-404.
2003: Liao Quan; Guo Junchao; Kleeff Jörg; Zimmermann Arthur; Büchler Markus W; Korc Murray; Friess Helmut
Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells.
Gastroenterology 2003;124(7):1830-45.
2003: Friess Helmut; Zhu Zhaowen; Liard Veronique; Shi Xin; Shrikhande Shailesh V; Wang Li; Lieb Klaus; Korc Murray; Palma Carla; Zimmermann Arthur; Reubi Jean Claude; Büchler Markus W
Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer.
Laboratory investigation; a journal of technical methods and pathology 2003;83(5):731-42.
2003: Ebert Matthias P A; Yu Jun; Hoffmann Juliane; Rocco Alba; Röcken Christoph; Kahmann Sabine; Müller Oliver; Korc Murray; Sung Joseph J; Malfertheiner Peter
Loss of beta-catenin expression in metastatic gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1708-14.
2003: Korc M
Pathways for aberrant angiogenesis in pancreatic cancer.
Molecular cancer 2003;2():8.
2002: Zhu Zhaowen; Kleeff Jörg; Kayed Hany; Wang Li; Korc Murray; Büchler Markus W; Friess Helmut
Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Molecular carcinogenesis 2002;35(3):138-47.
2002: Schneider Dominik; Kleeff Jörg; Berberat Pascal O; Zhu Zhaowen; Korc Murray; Friess Helmut; Büchler Markus W
Induction and expression of betaig-h3 in pancreatic cancer cells.
Biochimica et biophysica acta 2002;1588(1):1-6.
2002: Matsuda Kei; Idezawa Takenao; You Xue Juan; Kothari Nayantara H; Fan Hung; Korc Murray
Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
Cancer research 2002;62(19):5611-7.
2002: Zhu Zhaowen; Friess Helmut; Kleeff Jörg; Wang Li; Wirtz Martin; Zimmermann Arthur; Korc Murray; Büchler Markus W
Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer.
American journal of surgery 2002;184(1):78-83.
2002: Kornmann Marko; Ishiwata Toshiyuki; Matsuda Kei; Lopez Martha E; Fukahi Kimi; Asano Goro; Beger Hans G; Korc Murray
IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells.
Gastroenterology 2002;123(1):301-13.
2002: Kleeff Jörg; Fukahi Kimi; Lopez Martha E; Friess Helmut; Büchler Markus W; Sosnowski Barbara A; Korc Murray
Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.
Cancer gene therapy 2002;9(6):522-32.
2002: Tempia-Caliera Adrien A; Horvath Laszlo Zs; Zimmermann Arthur; Tihanyi Tibor T; Korc Murray; Friess Helmut; Büchler Markus W
Adhesion molecules in human pancreatic cancer.
Journal of surgical oncology 2002;79(2):93-100.
2002: Rowland-Goldsmith Melissa A; Maruyama Haruhisa; Matsuda Kei; Idezawa Takenao; Ralli Monica; Ralli Sonia; Korc Murray
Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
Molecular cancer therapeutics 2002;1(3):161-7.
2002: di Mola Fabio F; Friess Helmut; Riesle Erick; Koliopanos Alexander; Büchler Peter; Zhu Zhaowen; Brigstock David R; Korc Murray; Büchler Markus W
Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.
Annals of surgery 2002;235(1):60-7.
2001: Xu Z; Friess H; Solioz M; Aebi S; Korc M; Kleeff J; Büchler M W
Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
International journal of cancer. Journal international du cancer 2001;94(2):268-74.
2001: Kleeff J; Shi X; Bode H P; Hoover K; Shrikhande S; Bryant P J; Korc M; Büchler M W; Friess H
Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer.
Pancreas 2001;23(3):259-65.
2001: Rowland-Goldsmith M A; Maruyama H; Kusama T; Ralli S; Korc M
Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2931-40.
2001: Wildi S; Kleeff J; Maruyama H; Maurer C A; Büchler M W; Korc M
Overexpression of activin A in stage IV colorectal cancer.
Gut 2001;49(3):409-17.
2001: Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander A D; Korc M
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Cancer research 2001;61(14):5562-9.
2001: Friess H; Guo X Z; Tempia-Caliera A A; Fukuda A; Martignoni M E; Zimmermann A; Korc M; Büchler M W
Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2422-32.
2001: Luo J; Guo P; Matsuda K; Truong N; Lee A; Chun C; Cheng S Y; Korc M
Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo.
International journal of cancer. Journal international du cancer 2001;92(3):361-9.
2001: Zhu Z W; Friess H; Wang L; Abou-Shady M; Zimmermann A; Lander A D; Korc M; Kleeff J; Büchler M W
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.
Gut 2001;48(4):558-64.
2001: Zhu Z W; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler M W
Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):105-12.
2001: Kornmann M; Lopez M E; Beger H G; Korc M
Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(2):85-92.
2000: Fallon J; Reid S; Kinyamu R; Opole I; Opole R; Baratta J; Korc M; Endo T L; Duong A; Nguyen G; Karkehabadhi M; Twardzik D; Patel S; Loughlin S
In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(26):14686-91.
2000: Lu Z; Kleeff J; Shrikhande S; Zimmermann T; Korc M; Friess H; Büchler M W
Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer.
Pancreas 2000;21(3):240-7.
2000: Conejo J R; Kleeff J; Koliopanos A; Matsuda K; Zhu Z W; Goecke H; Bicheng N; Zimmermann A; Korc M; Friess H; Büchler M W
Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.
International journal of cancer. Journal international du cancer 2000;88(1):12-20.
2000: Wang L; Friess H; Zhu Z; Frigeri L; Zimmermann A; Korc M; Berberat P O; Büchler M W
Galectin-1 and galectin-3 in chronic pancreatitis.
Laboratory investigation; a journal of technical methods and pathology 2000;80(8):1233-41.
2000: Zhu Z; Kleeff J; Friess H; Wang L; Zimmermann A; Yarden Y; Büchler M W; Korc M
Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth.
Biochemical and biophysical research communications 2000;273(3):1019-24.
2000: Kleeff J; Kornmann M; Sawhney H; Korc M
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells.
International journal of cancer. Journal international du cancer 2000;86(3):399-407.
2000: Lopez M E; Korc M
A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
The Journal of biological chemistry 2000;275(21):15933-9.
2000: Ebert M P; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz H U; Roessner A; Korc M; Malfertheiner P
Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
Cancer research 2000;60(7):1995-2001.
2000: Kornmann M; Ishiwata T; Kleeff J; Beger H G; Korc M
Fas and Fas-ligand expression in human pancreatic cancer.
Annals of surgery 2000;231(3):368-79.
2000: Kornmann M; Ishiwata T; Maruyama H; Beger H G; Korc M
Coexpression of FAS and FAS-ligand in chronic pancreatitis: correlation with apoptosis.
Pancreas 2000;20(2):123-8.
2000: Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi J C; Büchler M W
Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):566-71.
2000: Kleeff J; Friess H; Korc M; Büchler M W
Chronic pancreatitis: pathogenesis and molecular aspects.
Annali italiani di chirurgia 2000;71(1):3-10.
2000: Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
International journal of cancer. Journal international du cancer 2000;85(1):27-34.
1999: Friess H; Wang L; Zhu Z; Gerber R; Schröder M; Fukuda A; Zimmermann A; Korc M; Büchler M W
Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.
Annals of surgery 1999;230(6):767-74; discussion 774-5.
1999: Friess H; Zhu Z W; di Mola F F; Kulli C; Graber H U; Andren-Sandberg A; Zimmermann A; Korc M; Reinshagen M; Büchler M W
Nerve growth factor and its high-affinity receptor in chronic pancreatitis.
Annals of surgery 1999;230(5):615-24.
1999: Wagner M; Kleeff J; Friess H; Büchler M W; Korc M
Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer.
Pancreas 1999;19(4):370-6.
1999: Wildi S; Kleeff J; Maruyama H; Maurer C A; Friess H; Büchler M W; Lander A D; Korc M
Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2840-7.
1999: Friess H; Fukuda A; Tang W H; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler M W
Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
World journal of surgery 1999;23(10):1010-8.
1999: Kleeff J; Wildi S; Kumbasar A; Friess H; Lander A D; Korc M
Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells.
Pancreas 1999;19(3):281-8.
1999: Kornmann M; Tangvoranuntakul P; Korc M
TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor.
International journal of cancer. Journal international du cancer 1999;83(2):247-54.
1999: Kleeff J; Friess H; Simon P; Susmallian S; Büchler P; Zimmermann A; Büchler M W; Korc M
Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer.
Digestive diseases and sciences 1999;44(9):1793-802.
1999: Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler M W; Falb D; Korc M
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Oncogene 1999;18(39):5363-72.
1999: Maruyama H; Kleeff J; Wildi S; Friess H; Büchler M W; Israel M A; Korc M
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.
The American journal of pathology 1999;155(3):815-22.
1999: Zhu Z; Friess H; diMola F F; Zimmermann A; Graber H U; Korc M; Büchler M W
Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2419-28.
1999: Kornmann M; Danenberg K D; Arber N; Beger H G; Danenberg P V; Korc M
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes.
Cancer research 1999;59(14):3505-11.
1999: di Mola F F; Friess H; Martignoni M E; Di Sebastiano P; Zimmermann A; Innocenti P; Graber H; Gold L I; Korc M; Büchler M W
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.
Annals of surgery 1999;230(1):63-71.
1999: Kleeff J; Wildi S; Friess H; Korc M
Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells.
Pancreas 1999;18(4):364-70.
1999: Kleeff J; Kusama T; Rossi D L; Ishiwata T; Maruyama H; Friess H; Büchler M W; Zlotnik A; Korc M
Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.
International journal of cancer. Journal international du cancer 1999;81(4):650-7.
1999: Kleeff J; Maruyama H; Ishiwata T; Sawhney H; Friess H; Büchler M W; Korc M
Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.
Gastroenterology 1999;116(5):1202-16.
1999: Ebert M; Yokoyama M; Ishiwata T; Friess H; Büchler M W; Malfertheiner P; Korc M
Alteration of fibroblast growth factor and receptor expression after acute pancreatitis in humans.
Pancreas 1999;18(3):240-6.
1999: Abou-Shady M; Baer H U; Friess H; Berberat P; Zimmermann A; Graber H; Gold L I; Korc M; Büchler M W
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
American journal of surgery 1999;177(3):209-15.
1999: Kleeff J; Maruyama H; Friess H; Büchler M W; Falb D; Korc M
Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer.
Biochemical and biophysical research communications 1999;255(2):268-73.
1999: Graber H U; Friess H; Kaufmann B; Willi D; Zimmermann A; Korc M; Büchler M W
ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer.
International journal of cancer. Journal international du cancer 1999;84(1):24-7.
1999: Kornmann M; Kleeff J; Debinski W; Korc M
Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
Anticancer research 1999;19(1A):125-31.
1999: di Mola F F; Friess H; Scheuren A; Di Sebastiano P; Graber H; Egger B; Zimmermann A; Korc M; Büchler M W
Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease.
Annals of surgery 1999;229(1):67-75.
1999: Friess H; Kleeff J; Korc M; Büchler M W
Molecular aspects of pancreatic cancer and future perspectives.
Digestive surgery 1999;16(4):281-90.
1998: Baer H U; Friess H; Abou-Shady M; Berberat P; Zimmermann A; Gold L I; Korc M; Büchler M W
Transforming growth factor betas and their receptors in human liver cirrhosis.
European journal of gastroenterology & hepatology 1998;10(12):1031-9.
1998: Guo X Z; Friess H; Di Mola F F; Heinicke J M; Abou-Shady M; Graber H U; Baer H U; Zimmermann A; Korc M; Büchler M W
KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1998;28(6):1481-8.
1998: Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler M W; Lander A D; Korc M
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
The Journal of clinical investigation 1998;102(9):1662-73.
1998: Kornmann M; Maruyama H; Bergmann U; Tangvoranuntakul P; Beger H G; White M F; Korc M
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.
Cancer research 1998;58(19):4250-4.
1998: Wagner M; Kleeff J; Lopez M E; Bockman I; Massaqué J; Korc M
Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
International journal of cancer. Journal international du cancer 1998;78(2):255-60.
1998: Friess H; Lu Z; Graber H U; Zimmermann A; Adler G; Korc M; Schmid R M; Büchler M W
bax, but not bcl-2, influences the prognosis of human pancreatic cancer.
Gut 1998;43(3):414-21.
1998: Kleeff J; Ishiwata T; Friess H; Büchler M W; Israel M A; Korc M
The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer.
Cancer research 1998;58(17):3769-72.
1998: Kleeff J; Ishiwata T; Friess H; Büchler M W; Korc M
Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
International journal of cancer. Journal international du cancer 1998;77(6):860-8.
1998: Maurer C A; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer H U; Korc M; Büchler M W
Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
Human pathology 1998;29(8):771-7.
1998: Kornmann M; Beger H G; Korc M
Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis.
Pancreas 1998;17(2):169-75.
1998: Kornmann M; Ishiwata T; Arber N; Beger H G; Korc M
Increased cyclin D1 expression in chronic pancreatitis.
Pancreas 1998;17(2):158-62.
1998: Friess H; Guo X Z; Berberat P; Graber H U; Zimmermann A; Korc M; Büchler M W
Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
International journal of cancer. Journal international du cancer 1998;79(4):349-55.
1998: Ishiwata T; Kornmann M; Beger H G; Korc M
Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis.
Gut 1998;43(1):134-9.
1998: Ishiwata T; Friess H; Büchler M W; Lopez M E; Korc M
Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer.
The American journal of pathology 1998;153(1):213-22.
1998: Kornmann M; Ishiwata T; Itakura J; Tangvoranuntakul P; Beger H G; Korc M
Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival.
Oncology 1998;55(4):363-9.
1998: Friess H; Duarte R; Kleeff J; Fukuda A; Tang W H; Graber H; Schilling M; Zimmermann A; Korc M; Büchler M W
The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Surgery 1998;124(1):79-86.
1998: Wagner M; Lopez M E; Cahn M; Korc M
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo.
Gastroenterology 1998;114(4):798-807.
1998: Ebert M; Kasper H U; Hernberg S; Friess H; Büchler M W; Roessner A; Korc M; Malfertheiner P
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis.
Digestive diseases and sciences 1998;43(3):567-74.
1998: Kleeff J; Korc M
Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.
The Journal of biological chemistry 1998;273(13):7495-500.
1998: Guo X Z; Friess H; Maurer C; Berberat P; Tang W H; Zimmermann A; Naef M; Graber H U; Korc M; Büchler M W
KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.
Cancer research 1998;58(4):753-8.
1998: Friess H; Lu Z; Riesle E; Uhl W; Bründler A M; Horvath L; Gold L I; Korc M; Büchler M W
Enhanced expression of TGF-betas and their receptors in human acute pancreatitis.
Annals of surgery 1998;227(1):95-104.
1998: Korc M
Role of growth factors in pancreatic cancer.
Surgical oncology clinics of North America 1998;7(1):25-41.
1998: Kornmann M; Arber N; Korc M
Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.
The Journal of clinical investigation 1998;101(2):344-52.
1997: Ishiwata T; Bergmann U; Kornmann M; Lopez M; Beger H G; Korc M
Altered expression of insulin-like growth factor II receptor in human pancreatic cancer.
Pancreas 1997;15(4):367-73.
1997: Lu Z; Friess H; Graber H U; Guo X; Schilling M; Zimmermann A; Korc M; Büchler M W
Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage.
Digestive diseases and sciences 1997;42(10):2054-63.
1997: Kornmann M; Ishiwata T; Beger H G; Korc M
Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions.
Oncogene 1997;15(12):1417-24.
1997: Hsiang D; Friess H; Büchler M W; Ebert M; Butler J; Korc M
Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis.
American journal of surgery 1997;174(3):242-6.
1997: Friess H; Cantero D; Graber H; Tang W H; Guo X; Kashiwagi M; Zimmermann A; Gold L; Korc M; Büchler M W
Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis.
Gastroenterology 1997;113(3):904-13.
1997: Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler M W; Korc M
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1309-16.
1997: Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson S A; Johnson G R; Korc M
Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
International journal of cancer. Journal international du cancer 1997;72(3):512-7.
1997: Naef M; Ishiwata T; Friess H; Büchler M W; Gold L I; Korc M
Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma.
International journal of cancer. Journal international du cancer 1997;71(2):131-7.
1997: Riesle E; Friess H; Zhao L; Wagner M; Uhl W; Baczako K; Gold L I; Korc M; Büchler M W
Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair.
Gut 1997;40(1):73-9.
1997: Cantero D; Friess H; Deflorin J; Zimmermann A; Bründler M A; Riesle E; Korc M; Büchler M W
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
British journal of cancer 1997;75(3):388-95.
1996: Wagner M; Cao T; Lopez M E; Hope C; van Nostrand K; Kobrin M S; Fan H U; Büchler M W; Korc M
Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum.
International journal of cancer. Journal international du cancer 1996;68(6):782-7.
1996: Guo X; Friess H; Graber H U; Kashiwagi M; Zimmermann A; Korc M; Büchler M W
KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
Cancer research 1996;56(21):4876-80.
1996: Horvath L Z; Friess H; Schilling M; Borisch B; Deflorin J; Gold L I; Korc M; Büchler M W
Altered expression of transforming growth factor-beta S in chronic renal rejection.
Kidney international 1996;50(2):489-98.
1996: Baldwin R L; Kobrin M S; Tran T; Pastan I; Korc M
Cytotoxic effects of TGF-alpha-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells.
Pancreas 1996;13(1):16-21.
1996: Baldwin R L; Friess H; Yokoyama M; Lopez M E; Kobrin M S; Büchler M W; Korc M
Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
International journal of cancer. Journal international du cancer 1996;67(2):283-8.
1996: Naef M; Yokoyama M; Friess H; Büchler M W; Korc M
Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma.
International journal of cancer. Journal international du cancer 1996;66(3):315-21.
1996: Lopez M E; Kobrin M S; Moriai T; Yokoyama M; Friess H; Büchler M; Korc M
Single-strand conformation polymorphism analysis of the epidermal growth factor receptor at codon 497.
Pancreas 1996;12(3):216-20.
1996: Bergmann U; Funatomi H; Kornmann M; Beger H G; Korc M
Increased expression of insulin receptor substrate-1 in human pancreatic cancer.
Biochemical and biophysical research communications 1996;220(3):886-90.
1996: Friess H; Berberat P; Schilling M; Kunz J; Korc M; Büchler M W
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.
Journal of molecular medicine (Berlin, Germany) 1996;74(1):35-42.
1995: Friess H; Yamanaka Y; Kobrin M S; Do D A; Büchler M W; Korc M
Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1413-20.
1995: Ebert M; Friess H; Büchler M W; Korc M
Differential distribution of human epidermal growth factor receptor family in acute pancreatitis.
Digestive diseases and sciences 1995;40(10):2134-42.
1995: Siddiqi I; Funatomi H; Kobrin M S; Friess H; Büchler M W; Korc M
Increased expression of keratinocyte growth factor in human pancreatic cancer.
Biochemical and biophysical research communications 1995;215(1):309-15.
1995: Ebert M; Yokoyama M; Friess H; Kobrin M S; Büchler M W; Korc M
Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer.
International journal of cancer. Journal international du cancer 1995;62(5):529-35.
1995: Bergmann U; Funatomi H; Yokoyama M; Beger H G; Korc M
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.
Cancer research 1995;55(10):2007-11.
1994: Ebert M; Yokoyama M; Friess H; Büchler M W; Korc M
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer.
Cancer research 1994;54(22):5775-8.
1994: Yokoyama M; Yamanaka Y; Friess H; Buchler M; Korc M
p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness.
Anticancer research 1994;14(6B):2477-83.
1994: Korc M; Friess H; Yamanaka Y; Kobrin M S; Buchler M; Beger H G
Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma.
Gut 1994;35(10):1468-73.
1994: Moriai T; Kobrin M S; Hope C; Speck L; Korc M
A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(21):10217-21.
1994: Kobrin M S; Funatomi H; Friess H; Buchler M W; Stathis P; Korc M
Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer.
Biochemical and biophysical research communications 1994;202(3):1705-9.
1994: Ebert M; Yokoyama M; Kobrin M S; Friess H; Lopez M E; Büchler M W; Johnson G R; Korc M
Induction and expression of amphiregulin in human pancreatic cancer.
Cancer research 1994;54(15):3959-62.
1994: Friess H; Yamanaka Y; Büchler M; Hammer K; Kobrin M S; Beger H G; Korc M
A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene.
Annals of surgery 1994;220(2):183-92.
1994: Friess H; Yamanaka Y; Büchler M; Kobrin M S; Tahara E; Korc M
Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
International journal of cancer. Journal international du cancer 1994;56(5):668-74.
1994: Friess H; Yamanaka Y; Büchler M; Beger H G; Do D A; Kobrin M S; Korc M
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis.
The American journal of pathology 1994;144(1):117-28.
1993: Friess H; Yamanaka Y; Büchler M; Ebert M; Beger H G; Gold L I; Korc M
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival.
Gastroenterology 1993;105(6):1846-56.
1993: Yamanaka Y; Friess H; Buchler M; Beger H G; Uchida E; Onda M; Kobrin M S; Korc M
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
Cancer research 1993;53(21):5289-96.
1993: Kobrin M S; Yamanaka Y; Friess H; Lopez M E; Korc M
Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas.
Cancer research 1993;53(20):4741-4.
1993: Yamanaka Y; Friess H; Kobrin M S; Büchler M; Kunz J; Beger H G; Korc M
Overexpression of HER2/neu oncogene in human pancreatic carcinoma.
Human pathology 1993;24(10):1127-34.
1993: Friess H; Yamanaka Y; Büchler M; Berger H G; Kobrin M S; Baldwin R L; Korc M
Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.
Cancer research 1993;53(12):2704-7.
1993: Yamanaka Y; Friess H; Büchler M; Beger H G; Gold L I; Korc M
Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas.
Diabetes 1993;42(5):746-56.
1993: Yamanaka Y; Friess H; Kobrin M S; Buchler M; Beger H G; Korc M
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.
Anticancer research 1993;13(3):565-9.
1993: Moriai T; Kobrin M S; Korc M
Cloning of a variant epidermal growth factor receptor.
Biochemical and biophysical research communications 1993;191(3):1034-9.
1993: Raitano A B; Korc M
Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.
Cancer research 1993;53(3):636-40.
1993: Korc M
Manganese as a modulator of signal transduction pathways.
Progress in clinical and biological research 1993;380():235-55.
1993: Baldwin R L; Korc M
Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1.
Growth factors (Chur, Switzerland) 1993;8(1):23-34.
1992: Korc M; Chandrasekar B; Yamanaka Y; Friess H; Buchier M; Beger H G
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.
The Journal of clinical investigation 1992;90(4):1352-60.
1991: Korc M; Chandrasekar B; Shah G N
Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.
Cancer research 1991;51(23 Pt 1):6243-9.
1991: Chandrasekar B; Korc M
Alteration of cholecystokinin-mediated phosphatidylinositol hydrolysis in pancreatic acini from insulin-deficient rats. Evidence for defective G protein activation.
Diabetes 1991;40(10):1282-91.
1991: Korc M; Chandrasekar B; Siwik S A
Cholecystokinin-induced phosphatidylinositol hydrolysis in rat pancreatic acinar cells: modulation by extracellular calcium and manganese.
Endocrinology 1991;129(1):39-46.
1991: Chandrasekar B; Korc M
Basic fibroblast growth factor is a calcium-mobilizing secretagogue in rat pancreatic acini.
Biochemical and biophysical research communications 1991;177(1):166-70.
1991: Korc M
Growth factors and pancreatic cancer.
International journal of pancreatology : official journal of the International Association of Pancreatology 1991;9():87-91.
1990: Brockenbrough J S; Korc M
Manganese modulates protein phosphorylation in the rat pancreas: in vitro evidence for cation selective regulation.
Pancreas 1990;5(5):589-97.
1990: Korc M
Potential role of the epidermal growth factor receptor in human pancreatic cancer.
International journal of pancreatology : official journal of the International Association of Pancreatology 1990;7(1-3):71-81.

Sign-in to see more